ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search

OR

CurrentAll Trials

DEFINE-FLAIR

Trial Details

Functional Lesion Assessment of Intermediate stenosis to guide Revascularisation

Design and Objective

Prospective, multi-center, double blind, randomised study to test the safety of deferral of stenting in physiological non-significant lesions in a clinical population of intermediate stenoses using iFR and FFR. The objective is to assess whether iFR is non-inferior to FFR when used to guide treatment of coronary stenosis with PCI.

Key inclusion criteria

-Age>18 years of age -Written informed consent -Eligible for coronary angiography and/or percutaneous coronary intervention -Coronary artery disease in one or more major vessels or their branches by coronary angiogram with coronary stenosis (40-70%) -Stable angina or ACS (non-culprit vessels only & outside primary intervention during acute STEMI)

Study Disclaimer Statement